Cochrane contributes to collaborative COVID-19 living evidence project

Project provides one location for decision makers to access information on COVID trials and synthesized results – now including vaccine dataAn international team of researchers from the Cochrane collaboration has compiled  living evidence related to COVID-19 for use by clinicians, policymakers, researchers, funders, guideline developers. Led byCochrane France in collaboration with  Cochrane Germany,  Cochrane Ireland,  Cochrane Chile,Cochrane South Africa, the  Cochrane Bias Methods Group and others, theCOVID-NMA project team brings together the latest evidence related to COVID-19, presenting data on trials registered all over the world, as well as living evidence synthesis of results from these trials.  The project provides one location for decision makers to access information on COVID trials and synthesized results that is frequently updated by researchers with expertise in evidence synthesis. The project includes two main parts: living mapping of ongoing research followed by living synthesis of study results as soon as they are available.Living mapping of ongoing researchEvery week the research team searches and extracts data from the WHO International Clinical Trials Registry Platform (ICTRP) to identify all RCTs evaluating the effectiveness of interventions for preventing and treating COVID-19 (including rehabilitation), as well as trials assessing vaccines.This feeds into two interactive living data visualizationson treatments andvaccines, developed in colla...
Source: Cochrane News and Events - Category: Information Technology Authors: Source Type: news